InnoPharmax
About
About Us
Organization
Our History
News
News
R&D
Pipeline
Anti-infection Agents
Contrast Agents
Oncology Agents
Immunological Agents
Drugs for Rare Diseases
Active Pharmaceutical Ingredient
Products
GemOral
N11005
Technologies
OralPAS®
OralPAS Pro®
MUCR™
Investors
Financial Information
Company Profile
Monthly Revenue
Financial Statements
Corporate Governance
Board Meeting
Committee
Internal Audit
Rule of Procedure
Corporate Social Responsibility
Shareholders Services
Annual Reports
Shareholders' Meetings
Announcements
Contact
Contacts
Contact Information
Career Opportunities
ZH-TW
Product and Pipeline
Pipeline
Anti-infection Agents
Contrast Agents
Oncology Agents
Immunological Agents
Drugs for Rare Diseases
Active Pharmaceutical Ingredient
Inpheno Tablets100 mg(Sapropterin Dihydrochloride)
>
Drugs for Rare Diseases
>
Product and Pipeline
>
home
Inpheno Tablets100 mg(Sapropterin Dihydrochloride)
Inpheno Tablets
100 mg
(Sapropterin Dihydrochloride)
Clicks:
8884
Inpheno Tablets is used as a supplement for those with a rare-genetic disorder called Phenylketonuria (PKU). People with PKU cannot metabolize phenylalanine due to either defective production of phenylalanine hydroxylase (PAH), or cannot produce a co-factor called BH4 to activate the enzyme. Inpheno is only effective for those KPU sufferers with defective production of BH4, where as PKU sufferers with defective PAH will have to avoid food that contain phenylalanine (such as diary and meat)
Composition : Sapropterin dihydrochloride 100mg
INNOPHARMAX
received exportation license in 2013 and obtained the US patent recordation of BH4 API process invention patents in 2014.
Back
uGear Design
-
Website Info.